OCTOBER 4TH

Upgrades (Friday, October 04, 2024)

• C.H. Robinson (CHRW): UBS, Neutral >> Buy, Price Target: $100 >> $140
• CVS Health (CVS): TD Cowen, Hold >> Buy, Price Target: $59 >> $85
• Digital Realty Trust (DLR): HSBC Securities, Reduce >> Hold, Price Target: $124 >> $160
• Equinix (EQIX): HSBC Securities, Hold >> Buy, Price Target: $865 >> $1000
• Diamondback Energy (FANG): BMO Capital Markets, Market Perform >> Outperform, Price Target: $205 >> $215
• Jacobs Solutions (J): Raymond James, Market Perform >> Outperform, Price Target: $160
• Morgan Stanley (MS): HSBC Securities, Hold >> Buy, Price Target: $118
• M&T Bank (MTB): Wolfe Research, Peer Perform >> Outperform, Price Target: $210
• Williams Cos (WMB): Morgan Stanley, Equal-Weight >> Overweight, Price Target: $52 >> $58
• BlackSky Technology (BKSY): Craig Hallum, Hold >> Buy, Price Target: $10

---

Downgrades (Friday, October 04, 2024)

• argenx (ARGX): Deutsche Bank, Buy >> Hold
• AZEK (AZEK): Loop Capital, Buy >> Hold, Price Target: $47
• BHP Group (BHP): Jefferies, Buy >> Hold, Price Target: $72 >> $68
• Chubb (CB): BofA Securities, Neutral >> Underperform, Price Target: $264 >> $275
• Canadian Nat’l Rail (CNI): BofA Securities, Buy >> Neutral, Price Target: $129 >> $122
• Dine Brands (DIN): Truist, Buy >> Hold, Price Target: $66 >> $37
• GE Vernova (GEV): HSBC Securities, Buy >> Hold, Price Target: $240 >> $255
• Gulfport Energy (GPOR): Evercore ISI, Outperform >> In-line, Price Target: $170
• Hartford Financial (HIG): BofA Securities, Buy >> Neutral, Price Target: $113 >> $121
• Li Auto (LI): Macquarie, Outperform >> Neutral, Price Target: $25 >> $33
• Mobileye Global (MBLY): UBS, Buy >> Neutral, Price Target: $20 >> $14
• PBF Energy (PBF): BMO Capital Markets, Outperform >> Market Perform, Price Target: $42 >> $35
• SAGE Therapeutics (SAGE): RBC Capital Markets, Outperform >> Sector Perform, Price Target: $10 >> $4
• Stellantis (STLA): RBC Capital Markets, Outperform >> Sector Perform
• Warner Music Group (WMG): BofA Securities, Neutral >> Underperform, Price Target: $33 >> $30
• Woodward (WWD): TD Cowen, Buy >> Hold, Price Target: $186 >> $160
• Vermilion Energy (VET): BMO Capital Markets, Outperform >> Market Perform

---

Coverage Initiated (Friday, October 04, 2024)

• ASP Isotopes (ASPI): Canaccord Genuity, Buy, Price Target: $4.5
• aTyr Pharma (ATYR): Wells Fargo, Overweight, Price Target: $17
• Curbline Properties (CURB): JP Morgan, Overweight, Price Target: $25
• GFL Environmental (GFL): Scotiabank, Sector Outperform, Price Target: $50
• iRhythm (IRTC): Goldman, Neutral, Price Target: $78
• LivaNova (LIVN): Goldman, Buy, Price Target: $65
• Lloyds Banking (LYG): Goldman, Neutral
• Miniso Group (MNSO): Citigroup, Buy, Price Target: $26.8
• NatWest Group plc (NWG): Goldman, Buy
• Republic Services (RSG): Scotiabank, Sector Perform, Price Target: $224
• Tandem Diabetes Care (TNDM): Goldman, Neutral, Price Target: $46
• Waste Connections (WCN): Scotiabank, Sector Perform, Price Target: $196
• Waste Management (WM): Scotiabank, Sector Perform, Price Target: $220
• AXIS Capital (AXS): TD Cowen, Buy, Price Target: $118

OCTOBER 3RD

Upgrades (October 3, 2024)

• BMW Group (BMWKY)
  • Brokerage Firm: Barclays
  • Ratings Change: Underweight to Equal Weight
• EQT Corp. (EQT)
  • Brokerage Firm: Citigroup
  • Ratings Change: Neutral to Buy
  • Price Target: $37 to $44
• EVgo Inc. (EVGO)
  • Brokerage Firm: JP Morgan
  • Ratings Change: Neutral to Overweight
  • Price Target: $7
• InvenTrust Properties (IVT)
  • Brokerage Firm: BofA Securities
  • Ratings Change: Neutral to Buy
  • Price Target: $30 to $33
• RTX (RTX)
  • Brokerage Firm: Deutsche Bank
  • Ratings Change: Sell to Hold
  • Price Target: $109 to $129
• Shoals Technologies (SHLS)
  • Brokerage Firm: Citigroup
  • Ratings Change: Sell to Neutral
  • Price Target: $5 to $5.5
• Wolverine (WWW)
  • Brokerage Firm: Exane BNP Paribas
  • Ratings Change: Neutral to Outperform
  • Price Target: $22
• Imperial Brands (IMBBY)
  • Brokerage Firm: Morgan Stanley
  • Ratings Change: Equal-Weight to Overweight
• EVgo Inc. (EVGO)
  • Brokerage Firm: TD Cowen
  • Ratings Change: Hold to Buy
  • Price Target: $5 to $7

Downgrades (October 3, 2024)

• Academy Sports + Outdoors (ASO)
  • Brokerage Firm: Evercore ISI
  • Ratings Change: Outperform to In-line
  • Price Target: $65 to $60
• Blue Bird (BLBD)
  • Brokerage Firm: ROTH MKM
  • Ratings Change: Buy to Neutral
  • Price Target: $48
• British American Tobacco (BTI)
  • Brokerage Firm: Morgan Stanley
  • Ratings Change: Overweight to Underweight
  • Price Target: $33
• CoreCard Corporation (CCRD)
  • Brokerage Firm: B. Riley Securities
  • Ratings Change: Buy to Neutral
  • Price Target: $19 to $15
• ChargePoint (CHPT)
  • Brokerage Firm: JP Morgan
  • Ratings Change: Overweight to Underweight
• Infosys (INFY)
  • Brokerage Firm: Investec
  • Ratings Change: Hold to Sell
• New Fortress Energy (NFE)
  • Brokerage Firm: Morgan Stanley
  • Ratings Change: Overweight to Equal-Weight
  • Price Target: $35 to $15
• National Grid (NGG)
  • Brokerage Firm: Citigroup
  • Ratings Change: Buy to Neutral
• Stellantis (STLA)
  • Brokerage Firm: Barclays
  • Ratings Change: Overweight to Equal Weight
• Tractor Supply (TSCO)
  • Brokerage Firm: Evercore ISI
  • Ratings Change: Outperform to In-line
  • Price Target: $300
• Voya Financial (VOYA)
  • Brokerage Firm: JP Morgan
  • Ratings Change: Overweight to Neutral
  • Price Target: $87
• Wipro (WIT)
  • Brokerage Firm: Investec
  • Ratings Change: Hold to Sell
• Wolfspeed (WOLF)
  • Brokerage Firm: Mizuho
  • Ratings Change: Neutral to Underperform
  • Price Target: $17 to $8
• Nestle (NSRGY)
  • Brokerage Firm: Citigroup
  • Ratings Change: Buy to Neutral
• Humana (HUM)
  • Brokerage Firm: Piper Sandler
  • Ratings Change: Overweight to Neutral
  • Price Target: $392 to $274
• Bilibili (BILI)
  • Brokerage Firm: Daiwa Securities
  • Ratings Change: Outperform to Neutral

Coverage Initiated (October 3, 2024)

• BridgeBio Pharma (BBIO)
  • Brokerage Firm: Oppenheimer
  • Ratings Change: Perform
• Concentrix (CNXC)
  • Brokerage Firm: Robert W. Baird
  • Ratings Change: Outperform
  • Price Target: $70
• Casella Waste (CWST)
  • Brokerage Firm: William Blair
  • Ratings Change: Outperform
• Dianthus Therapeutics (DNTH)
  • Brokerage Firm: Oppenheimer
  • Ratings Change: Outperform
  • Price Target: $48
• Enovis Corporation (ENOV)
  • Brokerage Firm: JMP Securities
  • Ratings Change: Market Outperform
  • Price Target: $62
• nLIGHT (LASR)
  • Brokerage Firm: Cantor Fitzgerald
  • Ratings Change: Overweight
  • Price Target: $15.5
• Ligand Pharma (LGND)
  • Brokerage Firm: Oppenheimer
  • Ratings Change: Outperform
  • Price Target: $135
• Larimar Therapeutics (LRMR)
  • Brokerage Firm: Wedbush
  • Ratings Change: Outperform
  • Price Target: $22
• Republic Services (RSG)
  • Brokerage Firm: William Blair
  • Ratings Change: Outperform
• Sila Realty Trust (SILA)
  • Brokerage Firm: Janney
  • Ratings Change: Buy
  • Price Target: $28
• Two Harbors Investment (TWO)
  • Brokerage Firm: Compass Point
  • Ratings Change: Buy
  • Price Target: $15.75
• Verona Pharma (VRNA)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Overweight
  • Price Target: $50
• Waste Management (WM)
  • Brokerage Firm: William Blair
  • Ratings Change: Outperform
• South Bow Corporation (SOBO)
  • Brokerage Firm: RBC Capital Markets
  • Ratings Change: Outperform
• South Bow Corporation (SOBO)
  • Brokerage Firm: National Bank Financial
  • Ratings Change: Sector Perform

OCTOBER 2:
Upgrades

• Bank of Hawaii (BOH)
  • Brokerage: Keefe Bruyette
  • Rating: Underperform to Mkt Perform
  • Price Target: $60 to $67
• Salesforce (CRM)
  • Brokerage: Northland Capital
  • Rating: Market Perform to Outperform
  • Price Target: $400
• CVB Financial (CVBF)
  • Brokerage: Keefe Bruyette
  • Rating: Mkt Perform to Outperform
  • Price Target: $20 to $22
• Diamondback Energy (FANG)
  • Brokerage: Barclays
  • Rating: Equal Weight to Overweight
  • Price Target: $216 to $210
• Hanmi Financial (HAFC)
  • Brokerage: Keefe Bruyette
  • Rating: Mkt Perform to Outperform
  • Price Target: $20 to $22
• Home Depot (HD)
  • Brokerage: Gordon Haskett
  • Rating: Accumulate to Buy
  • Price Target: $450
• M&T Bank (MTB)
  • Brokerage: Evercore ISI
  • Rating: In-line to Outperform
  • Price Target: $187 to $210
• Par Pacific (PARR)
  • Brokerage: JP Morgan
  • Rating: Neutral to Overweight
  • Price Target: $36 to $30
• Rio Tinto (RIO)
  • Brokerage: Berenberg
  • Rating: Hold to Buy
• Range Resources (RRC)
  • Brokerage: Barclays
  • Rating: Underweight to Equal Weight
  • Price Target: $35 to $34
• Science Applications (SAIC)
  • Brokerage: JP Morgan
  • Rating: Neutral to Overweight
  • Price Target: $150 to $170
• Sphere Entertainment Co. (SPHR)
  • Brokerage: Wolfe Research
  • Rating: Peer Perform to Outperform
  • Price Target: $60
• Tompkins Finl (TMP)
  • Brokerage: Keefe Bruyette
  • Rating: Mkt Perform to Outperform
  • Price Target: $59 to $68
• Towne Bank (TOWN)
  • Brokerage: Keefe Bruyette
  • Rating: Mkt Perform to Outperform
  • Price Target: $35 to $40
• Emcore (EMKR)
  • Brokerage: Craig Hallum
  • Rating: Hold to Buy
  • Price Target: $3
• COSCO SHIPPING Holdings (CICOF)
  • Brokerage: Goldman
  • Rating: Sell to Neutral
• British Land (BTLCY)
  • Brokerage: Deutsche Bank
  • Rating: Hold to Buy
• Engie SA (ENGIY)
  • Brokerage: BofA Securities
  • Rating: Underperform to Neutral
• Man Group (MNGPF)
  • Brokerage: Deutsche Bank
  • Rating: Hold to Buy
• Daqo New Energy (DQ)
  • Brokerage: HSBC Securities
  • Rating: Hold to Buy
• Telefonica S.A. (TEF)
  • Brokerage: HSBC Securities
  • Rating: Reduce to Hold

---

Downgrades

• Booz Allen Hamilton (BAH)
  • Brokerage: JP Morgan
  • Rating: Neutral to Underweight
  • Price Target: $154 to $158
• Charles River (CRL)
  • Brokerage: BofA Securities
  • Rating: Buy to Neutral
  • Price Target: $250 to $215
• Esquire Financial (ESQ)
  • Brokerage: Keefe Bruyette
  • Rating: Outperform to Mkt Perform
  • Price Target: $68 to $72
• First Mid-Illinois Bancshares (FMBH)
  • Brokerage: Keefe Bruyette
  • Rating: Outperform to Mkt Perform
• GE Vernova (GEV)
  • Brokerage: Raymond James
  • Rating: Outperform to Mkt Perform
• Harley-Davidson (HOG)
  • Brokerage: Robert W. Baird
  • Rating: Outperform to Neutral
  • Price Target: $44 to $40
• IBM (IBM)
  • Brokerage: DZ Bank
  • Rating: Buy to Hold
  • Price Target: $215
• Mobileye Global (MBLY)
  • Brokerage: Exane BNP Paribas
  • Rating: Neutral to Underperform
  • Price Target: $12
• Shattuck Labs (STTK)
  • Brokerage: Needham
  • Rating: Buy to Hold
• MercadoLibre (MELI)
  • Brokerage: JP Morgan
  • Rating: Overweight to Neutral
  • Price Target: $2400
• Bank of N.T. Butterfield & Son (NTB)
  • Brokerage: Keefe Bruyette
  • Rating: Outperform to Mkt Perform
  • Price Target: $44 to $41
• PBF Energy (PBF)
  • Brokerage: JP Morgan
  • Rating: Overweight to Neutral
  • Price Target: $53 to $40
• Primo Water (PRMW)
  • Brokerage: Raymond James
  • Rating: Outperform to Mkt Perform
• PVH (PVH)
  • Brokerage: BofA Securities
  • Rating: Buy to Neutral
  • Price Target: $130 to $107
• SITE Centers (SITC)
  • Brokerage: Wells Fargo
  • Rating: Overweight to Equal Weight
  • Price Target: $19
• Shattuck Labs (STTK)
  • Brokerage: Citigroup
  • Rating: Buy to Neutral
  • Price Target: $8 to $2
• Tempus AI (TEM)
  • Brokerage: BofA Securities
  • Rating: Buy to Neutral
  • Price Target: $45 to $60
• T-Mobile US (TMUS)
  • Brokerage: Raymond James
  • Rating: Strong Buy to Outperform
  • Price Target: $208 to $221
• ZIM Integrated Shipping (ZIM)
  • Brokerage: Jefferies
  • Rating: Buy to Hold
  • Price Target: $25
• Kellanova (K)
  • Brokerage: Argus
  • Rating: Buy to Hold
• Humana (HUM)
  • Brokerage: Stephens
  • Rating: Overweight to Equal-Weight
  • Price Target: $400 to $250
• Bureau Veritas Registre (BVRDF)
  • Brokerage: JP Morgan
  • Rating: Overweight to Neutral
• Humana (HUM)
  • Brokerage: Leerink Partners
  • Rating: Outperform to Market Perform
  • Price Target: $400 to $250
• Agilon Health (AGL)
  • Brokerage: BofA Securities
  • Rating: Buy to Underperform
  • Price Target: $3
• Humana (HUM)
  • Brokerage: BofA Securities
  • Rating: Neutral to Underperform
  • Price Target: $376 to $247

OCTOBER 1:

Upgrades

• Becton Dickinson (BDX): Citigroup upgraded from Neutral to Buy; price target increased from $255 to $275.
• Bio-Rad Labs (BIO): Citigroup upgraded from Neutral to Buy; price target increased from $350 to $400.
• Anheuser-Busch InBev (BUD): Citigroup upgraded from Neutral to Buy.
• Clorox (CLX): Jefferies upgraded from Hold to Buy; price target raised from $174 to $187.
• CareTrust REIT (CTRE): Wells Fargo upgraded from Equal Weight to Overweight; price target raised from $28 to $34.
• Datadog (DDOG): DA Davidson upgraded from Neutral to Buy; price target raised from $115 to $140.
• Ford Motor (F): Goldman upgraded from Neutral to Buy; price target raised from $12 to $13.
• Roku (ROKU): MoffettNathanson upgraded from Sell to Neutral; no price target provided.
• Range Resources (RRC): Wells Fargo upgraded from Equal Weight to Overweight; price target increased from $35 to $39.
• Sabra Health Care REIT (SBRA): Wells Fargo upgraded from Equal Weight to Overweight; price target increased from $16 to $20.
• Atlassian (TEAM): Raymond James upgraded from Market Perform to Outperform; no price target provided.
• TTEC Holdings (TTEC): Guggenheim upgraded from Sell to Neutral.
• Ventas (VTR): Wells Fargo upgraded from Equal Weight to Overweight; price target raised from $61 to $71.
• Alcoa (AA): BofA Securities upgraded from Neutral to Buy; price target raised from $43 to $52.
• Steel Dynamics (STLD): BofA Securities upgraded from Neutral to Buy; price target raised from $140 to $155.
• Coherent (COHR): Susquehanna upgraded from Neutral to Positive; no price target provided.
• Dine Brands (DIN): Wedbush upgraded from Neutral to Outperform; price target raised from $34 to $47.

Downgrades

• Antero Resources (AR): Wells Fargo downgraded from Overweight to Underweight; price target decreased from $34 to $25.
• Popular (BPOP): Wells Fargo downgraded from Overweight to Equal Weight; price target decreased from $115 to $105.
• CDW (CDW): Citigroup downgraded from Buy to Neutral; price target decreased from $250 to $245.
• Charles River (CRL): Citigroup downgraded from Neutral to Sell; price target decreased from $215 to $175.
• First Interstate Bancsystem (FIBK): Wells Fargo downgraded from Equal Weight to Underweight; price target decreased from $30 to $28.
• Fluence (FLNC): Citigroup downgraded from Buy to Neutral; price target decreased from $32 to $24.
• Fastly (FSLY): Raymond James downgraded from Strong Buy to Market Perform.
• General Dynamics (GD): Wells Fargo downgraded from Overweight to Equal Weight; price target decreased from $334 to $317.
• Gritstone bio (GRTS): JMP Securities downgraded from Market Outperform to Market Perform.
• Hologic (HOLX): Citigroup downgraded from Buy to Neutral; price target decreased from $95 to $85.
• HP Inc. (HPQ): Citigroup downgraded from Buy to Neutral; price target decreased from $37 to $35.
• IGM Biosciences (IGMS): Truist downgraded from Buy to Hold; price target decreased from $24 to $12.
• IGM Biosciences (IGMS): JP Morgan downgraded from Neutral to Underweight; price target decreased from $12 to $9.
• Interpublic (IPG): JP Morgan downgraded from Overweight to Neutral; price target decreased from $36 to $33.
• Magnolia Oil & Gas (MGY): Wells Fargo downgraded from Equal Weight to Underweight; price target decreased from $26 to $22.
• National Health (NHI): Wells Fargo downgraded from Overweight to Equal Weight; price target increased from $81 to $86.
• PagSeguro Digital (PAGS): Itau BBA downgraded from Outperform to Market Perform.
• Pinnacle Finl (PNFP): Wells Fargo downgraded from Overweight to Equal Weight; price target unchanged at $100.
• Kering SA (PPRUY): Goldman downgraded from Neutral to Sell.
• Synovus (SNV): Wells Fargo downgraded from Overweight to Equal Weight.
• Aptiv (APTV): Fox Advisors downgraded from Overweight to Equal Weight.
• EchoStar (SATS): Raymond James downgraded from Strong Buy to Market Perform.
• New Fortress Energy (NFE): Deutsche Bank downgraded from Hold to Sell; price target decreased from $21 to $7.6.
• Highwoods Prop (HIW): Deutsche Bank downgraded from Buy to Hold; price target unchanged at $35.
• Franco-Nevada (FNV): BofA Securities downgraded from Buy to Neutral; price target decreased from $142 to $139.
• MaxLinear (MXL): Susquehanna downgraded from Positive to Neutral; no price target provided.
• Brinker (EAT): Argus downgraded from Buy to Hold.
• TFI International (TFII): Stephens downgraded from Overweight to Equal-Weight; price target decreased from $176 to $149.
• Walt Disney (DIS): Raymond James downgraded from Outperform to Market Perform.
• CNX Resources (CNX): Tudor, Pickering, Holt & Co. downgraded from Hold to Sell.
• Shattuck Labs (STTK): H.C. Wainwright downgraded from Buy to Neutral.

Coverage Initiated

• Equifax (EFX): UBS initiated with a Buy rating; price target set at $360.
• Epsilon Energy (EPSN): ROTH MKM initiated with a Buy rating; price target set at $7.
• Fair Isaac (FICO): UBS initiated with a Neutral rating; price target set at $2100.
• Alphabet (GOOG): Pivotal Research Group initiated with a Buy rating; price target set at $215.
• Incyte (INCY): Wolfe Research initiated with an Outperform rating; price target set at $84.
• LCI Industries (LCII): Raymond James initiated with a Market Perform rating; no price target provided.
• Neumora Therapeutics (NMRA): H.C. Wainwright initiated with a Buy rating; price target set at $30.
• Xenon Pharmaceuticals (XENE): H.C. Wainwright initiated with a Buy rating; price target set at $53.
• Meta Platforms (META): Pivotal Research Group initiated with a Buy rating; price target set at $780.
• Labcorp Holdings Inc. (LH): Piper Sandler initiated with a Neutral rating; price target set at $235.
• LATAM Airlines (LTM): Morgan Stanley initiated with an Overweight rating; price target set at $40.
• Patrick Industries (PATK): Raymond James initiated with an Outperform rating; price target set at $160.
• TransUnion (TRU): UBS initiated with a Neutral rating; price target set at $110.
• Perspective Therapeutics (CATX): Wedbush initiated with an Outperform rating; price target set at $25.
• Danaher (DHR): Stephens initiated with an Overweight rating; price target set at $315.
• Euronet (EEFT): Oppenheimer initiated with an Outperform rating; price target set at $121.
• Shift4 Payments (FOUR): Oppenheimer initiated with an Outperform rating; price target set at $109.
• MoneyLion (ML): Oppenheimer initiated with a Perform rating; no price target provided.
• Pagaya (PGY): Oppenheimer initiated with an Outperform rating; price target set at $12.
• Thermo Fisher (TMO): Stephens initiated with an Overweight rating; price target set at $680.
• SharkNinja (SN): Oppenheimer initiated with an Outperform rating; price target set at $120.
• Clearway Energy (CWEN): Exane BNP Paribas initiated with an Outperform rating; price target set at $36.
• NextEra Energy Partners (NEP): Exane BNP Paribas initiated with an Underperform rating; price target set at $15.
• Snowflake (SNOW): Argus initiated with a Hold rating; no price target provided.

SEPTEMBER 30:

Upgrades

• Accenture (ACN): TD Cowen upgraded from Hold to Buy, price target raised from $321 to $400.
• Amerant Bancorp (AMTB): Piper Sandler upgraded from Neutral to Overweight, price target remains at $26.5.
• Brookfield Renewable Partners (BEP): UBS upgraded from Neutral to Buy, price target raised from $24 to $31.
• Brown-Forman (BF.B): Barclays upgraded from Equal Weight to Overweight, price target raised from $43 to $53.
• BlackLine (BL): Morgan Stanley upgraded from Equal-Weight to Overweight, price target raised from $60 to $70.
• Cadence Bank (CADE): Morgan Stanley upgraded from Equal-Weight to Overweight, price target raised from $36 to $39.
• Walt Disney (DIS): Seaport Research Partners upgraded from Neutral to Buy, no price target provided.
• Hess (HES): Wolfe Research upgraded from Peer Perform to Outperform, price target remains at $150.
• U.S. Bancorp (USB): Morgan Stanley upgraded from Equal-Weight to Overweight, price target raised from $54 to $57.
• Westlake Corporation (WLK): Barclays upgraded from Equal Weight to Overweight, price target raised from $162 to $180.
• Zions Bancorp (ZION): Morgan Stanley upgraded from Underweight to Equal-Weight, price target remains at $54.
• TC Energy (TRP): UBS upgraded from Neutral to Buy, no price target provided.

Downgrades

• Bruker (BRKR): Wolfe Research downgraded from Outperform to Peer Perform.
• Commerce Bancshares (CBSH): Morgan Stanley downgraded from Overweight to Equal-Weight, price target lowered from $66 to $64.
• Charter Comm (CHTR): Wolfe Research downgraded from Peer Perform to Underperform, no price target provided.
• Enbridge (ENB): Jefferies downgraded from Buy to Hold.
• Freeport-McMoRan (FCX): Scotiabank downgraded from Sector Outperform to Sector Perform, price target remains at $52.
• Frontier Communications Parent (FYBR): Wolfe Research downgraded from Outperform to Peer Perform.
• Interpublic (IPG): Exane BNP Paribas downgraded from Neutral to Underperform.
• JPMorgan Chase (JPM): Morgan Stanley downgraded from Overweight to Equal-Weight, price target slightly raised from $220 to $224.
• Procter & Gamble (PG): Barclays downgraded from Overweight to Equal Weight, price target remains at $163.
• EnLink Midstream (ENLC): UBS downgraded from Buy to Neutral, price target remains at $16.

Coverage Initiated

• BioLife Solutions (BLFS): H.C. Wainwright initiated with a Buy rating, price target at $29.
• Crescent Capital BDC (CCAP): Ladenburg Thalmann initiated with a Buy rating, price target at $20.
• Celldex Therapeutics (CLDX): Goldman initiated with a Neutral rating, price target at $45.
• Horizon Bancorp (HBNC): Hovde Group initiated with an Outperform rating, price target at $18.
• Navient (NAVI): BofA Securities initiated with a Neutral rating, price target at $17.
• Permian Resources (PR): Goldman initiated with a Buy rating, price target at $19.
• ProKidney Corp. (PROK): JP Morgan initiated with a Neutral rating, no price target provided.
• Skye Bioscience (SKYE): Scotiabank initiated with a Sector Outperform rating, price target at $20.
• Tenax Therapeutics (TENX): William Blair initiated with an Outperform rating.
• Verastem (VSTM): Guggenheim initiated with a Buy rating, price target at $13.
• Klaviyo (KVYO): The Benchmark Company initiated with a Buy rating, price target at $42.
• OSI Systems (OSIS): BofA Securities initiated with a Buy rating, price target at $175.